CORZ — Stock Film
STOCK FILMSCENE 1/11CORZ · $29.16
Stock Expert AI presents
CORZ
Core Scientific, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Core Scientific, Inc. A quick introduction.

On the stock market since 2024, it operates in the world of technology. It has 325 employees. Now — the numbers.

on the stock market since 2024
325 employees
$9.3B market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.9.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales have been shrinking.

An average decline of 13% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$544.5M
2021
$640.3M
2022
$502.4M
2023
$510.7M
2024
$319M
2025
In the vault right now:
$0
DEBT: $1.1B
At this pace, that money lasts about 1.1 years.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
15
very weak

Clearly below the class average.

FINANCIAL STRENGTH
45
weak

Clearly below the class average.

VALUATION
13
very weak

Clearly below the class average.

GROWTH
5
very weak

Clearly below the class average.

PRICE MOMENTUM
77
strong

Clearly above the class average — a step short of the very top.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Executives aren’t buying3/10
Costs eat into the margin4/10
WORTH WATCHING

Executive Buying: The trades send no strong signal of confidence.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $319.0M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Analysts’ target sits above today’s price

The average analyst price target is $33.5715% above today’s price.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $288.6M against $319.0M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
A wildly swinging price

This stock swings about 5.5 times as much as the market average. Big rallies — and big drops — can both happen fast.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts about 1.1 years. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, CORZ sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: CORZ is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

Analysts’ average target sits above today’s price, yet the valuation grade (13/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film